Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Gastroenterology|July 3, 2015
Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinomaHugo Ford, Ioannis Gounaris
The Annals of Thoracic Surgery|January 25, 2012
Primitive neuroectodermal tumor of the heartNnamdi Nwaejike, Doris Rassl, Hugo Ford, et al.
British Journal of Cancer|February 17, 2016
Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level dataTobias Janowitz, Peter Thuss-Patience, Andrea Marshall, et al.
British Journal of Cancer|October 21, 2015
Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinomaNadeera De Silva, Laura Schulz, Anna Paterson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancerTamas Hickish, Jim Cassidy, David Propper, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2023
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trialJohn V Reynolds, Shaun R Preston, Brian O'Neill, et al.
Pageof 1